tomeko

GTP cyclohydrolase I deficiency with hyperphenylalaninemia

Just diagnosed with GTP cyclohydrolase I deficiency with hyperphenylalaninemia?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees GTP cyclohydrolase I deficiency with hyperphenylalaninemia, look for clinical trials, and connect with others living with it — all in one place.

Open the full GTP cyclohydrolase I deficiency with hyperphenylalaninemia hub →

Overview

GTP cyclohydrolase I deficiency with hyperphenylalaninemia is a rare condition. Also known as GTPCH deficiency, Hyperphenylalaninemia due to GTP cyclohydrolase deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for GTP cyclohydrolase I deficiency with hyperphenylalaninemia so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:2102 · OMIM 233910 · ICD-10 E70.1 · GARD 0002844

Find care for GTP cyclohydrolase I deficiency with hyperphenylalaninemia

Authoritative references for GTP cyclohydrolase I deficiency with hyperphenylalaninemia

Common questions

I was just diagnosed with GTP cyclohydrolase I deficiency with hyperphenylalaninemia — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees GTP cyclohydrolase I deficiency with hyperphenylalaninemia, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for GTP cyclohydrolase I deficiency with hyperphenylalaninemia?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat GTP cyclohydrolase I deficiency with hyperphenylalaninemia, filtered to your area.

Are there clinical trials for GTP cyclohydrolase I deficiency with hyperphenylalaninemia?

Tomeko shows live, recruiting studies for GTP cyclohydrolase I deficiency with hyperphenylalaninemia from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com